Canada Approves Generic Ozempic, Slashes Costs

0:00It's April 29th. Welcome in. This is Canada News Today, where local news meets AI. I'm Corey with the story. Canada just made history as the first G7 nation to approve a generic semi-glutide injection, the key ingredient in the hit drug oz. Health Canada gave the Greenlight Tuesday to a version from Dr. Reddy's Laboratories, the India-based pharmacist with U.S. headquarters in New. Jersey. Eight more generic versions are waiting in the wings for approval. All deemed pharmaceutical equivalent to the original biologic. Officials stress these complex synthetics match up on safety, efficacy, and quality. For Canadians shelling out hundreds of dollars monthly on brand name oz. Often prescribed off label for weight loss. This opens the door to real. Relief. Dual source generics can hit 50% of the brand price, while multi-source ones drop to 25-35%. Many of beat everyone to it. O.K. Dr. Reddy's generics in March after the patent laps there.

1:01The company filed in Canada earlier this year. Health Canada plans to keep a close eye on all these generics for ongoing safety and effectiveness, setting the stage for major cost savings across. The health system and for everyday patients.